Company / Profit Margin
CASTLE BIOSCIENCES INC Profit Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-7.0%
FY2025
5-year range
-49.0% / 5.5%
FY2021-FY2025
Trend
-227.9%
vs FY2024
Sector context
#116 of 155
Health Care
What the data says
Profit Margin changed -228% YoY in FY2025, a notable deviation from the 7-year average annual change of -48%.
Based on SEC 10-K filings.
-7.0% in FY2025 with a 5-year CAGR of +9.4%.
Improved from -26.2% to -7.0% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +42.0pp
- 5-Year Change
- +9.4pp
- 10-Year Change
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 155This company -7.0% Sector average -254.2%
▼
+97.2% above sector average
Key checks
Key Insights
- In FY2025, profit margin decreased 227.9% year-over-year.
- Currently 247.2pp above the Health Care sector average.
- Peak profit margin was recorded in FY2019.
- Lowest profit margin in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -7.0% | -227.9% |
| FY2024 | 5.5% | +121.0% |
| FY2023 | -26.2% | +46.6% |
| FY2022 | -49.0% | -47.3% |
| FY2021 | -33.3% | -102.6% |
| FY2020 | -16.4% | -261.5% |
| FY2019 | 10.2% | +136.4% |
| FY2018 | -27.9% | - |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026